Opportunities Preloader

Please Wait.....

Report

Global Premature Ejaculation Therapeutics Market - Focused Insights 2024-2029

Market Report I 2023-12-06 I 109 Pages I Arizton Advisory & Intelligence

REPORT OVERVIEW

This report offers market size & forecast data for the global premature ejaculation therapeutics market. The revenue generated from the sale of drugs, including off-label products, is included in the report. The revenue generated from the devices used to manage premature ejaculation, physicians' fees, and other service-related costs is excluded from the report's scope. This report provides a comprehensive and current market scenario of the global premature ejaculation therapeutics market, including the global premature ejaculation therapeutics market size, anticipated market forecast, relevant market segmentations, and industry trends.
The study considers a detailed scenario of the present global premature ejaculation therapeutics market and its market dynamics for 2024?2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

Premature ejaculation (PE) is a male sexual dysfunction characterized by the inability to delay ejaculation for more than a minute after penetration that leads to negative personal consequences, such as distress, frustration, and/or the avoidance of sexual intimacy. Premature ejaculation (PE) is a common sexual problem that affects about 20-30% of men in the sexually active age group leading to psychological stress and loss of self-esteem.

KEY HIGHLIGHTS

- The global premature ejaculation therapeutics market was valued at $2,456.71 million in 2023 and is expected to reach $4,062.34 million by 2029, growing at a CAGR of 8.74%. The market growth is mainly attributed to the rising prevalence of premature ejaculation among men globally.
- In 2023, North America and Europe dominated the market with a market share of 43.79% and 25.02%, respectively. APAC is expected to be the fastest-growing market for premature ejaculation (PE) therapeutics in terms of revenue during the forecast period, with a CAGR of 10.56%.
- By drug class, the Selective Serotonin Reuptake Inhibitors (SSRIs) segment was valued at $1,064.41 million in 2023 and is expected to reach $1,759.00 million by 2029, growing at a CAGR of 8.73%. The increased recommendation of SSRIs by healthcare professionals is one of the key factors for the growth of the segment worldwide. SSRIs are considered effective drugs for the treatment of premature ejaculation therapeutics market.
- By Route of Administration, the oral therapeutics segment was valued at $1,847.37 million in 2023 and is expected to reach $2,975.67 million by 2029, growing at a CAGR of 8.27%. The increased recommendation of oral therapeutics by healthcare professionals is one of the key factors for the growth of the segment worldwide. Also, the growing pervasiveness of premature ejaculation and the increasing uptake of generic off-label medications are the key factors enabling the growth of the oral ROA segment.
- By age group, the people aged below 45 years segment was valued at $1,519.11 million in 2023 and is expected to reach $2,536.12 million by 2029, growing at a CAGR of 8.92%. The rise in the prevalence of premature ejaculation in the younger population is the major factor contributing to the market growth during the forecast period.
- Plethora Solutions, Pfizer, Eli Lilly and Company, GSK plc, and the Menarini group are some leading players currently dominating the global premature ejaculation therapeutics market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the premature ejaculation therapeutics market and access commercially launched products.

VENDORS LIST

- Plethora Solutions
- Pfizer
- Absorption Pharmaceuticals
- Eli Lilly and Company
- GSK plc
- Bayer AG
- MidasCare
- Pound International
- Momentum Management
- Reckitt Benckiser Group
- Recordati
- Royalty Pharma
- Shibari
- Johnson & Johnson
- The Menarini Group
- Futura Medical
- Niksan Pharmaceuticals
- Amneal Pharmaceuticals

REPORT HIGHLIGHTS

PRODUCT SEGMENTATION & FORECAST

- Drug Class
? Selective Serotonin Re-uptake Inhibitors (SSRIs)
? Phosphodiesterase type 5 (PDE5) inhibitors
? Anesthetic Agents
? Others
- Route of Administration
? Oral Therapeutics
? Topical Therapeutics
- Age Group
? Below 45 years
? Above 45 years

MARKET STRUCTURE

- Market Dynamics
- Competitive Landscape of PE Therapeutics Market
- Key Vendors
- Other Prominent Vendors

APPENDIX

- Research Methodology
- Abbreviations
- About Arizton

CHAPTER - 1: PE Therapeutics Market Overview
- Executive Summary
- Key Findings

CHAPTER - 2: PE Therapeutics Market
- GLOBAL: Projected Revenue of PE Therapeutics Market (2023-2029; $Millions)

CHAPTER - 3: PE Therapeutics Market Segmentation Data
- GLOBAL: Projected Revenue by Drug Class (2023-2029; $Millions)
o SSRIs
o PDE-5 Inhibitors
o Anesthetic Agents
o Others
- GLOBAL: Projected Revenue by Route of Administration (2023-2029; $Millions)
o Oral Therapeutics
o Topical Therapeutics
- GLOBAL: Projected Revenue by Age Group (2023-2029; $Millions)
o Below 45 years
o Above 45 years

CHAPTER - 4: Key Regions Overview
- North America: Projected Revenue of PE Therapeutics Market (2023-2029; $Millions)
o Projected Revenue of PE Therapeutics Market in US
o Projected Revenue of PE Therapeutics Market in Canada
- Europe: Projected Revenue of PE Therapeutics Market (2023-2029; $Millions)
o Projected Revenue of PE Therapeutics Market in Germany
o Projected Revenue of PE Therapeutics Market in UK
o Projected Revenue of PE Therapeutics Market in France
o Projected Revenue of PE Therapeutics Market in Italy
o Projected Revenue of PE Therapeutics Market in Spain
- APAC: Projected Revenue of PE Therapeutics Market (2023-2029; $Millions)
o Projected Revenue of PE Therapeutics Market in Japan
o Projected Revenue of PE Therapeutics Market in India
o Projected Revenue of PE Therapeutics Market in China
- Latin America: Projected Revenue of PE Therapeutics Market (2023-2029; $Millions)
o Projected Revenue of PE Therapeutics Market in Brazil
o Projected Revenue of PE Therapeutics Market in Mexico
o Projected Revenue of PE Therapeutics Market in Argentina
- Middle East & Africa: Projected Revenue of PE Therapeutics Market (2023-2029; $Millions)
o Projected Revenue of PE Therapeutics Market in Turkey
o Projected Revenue of PE Therapeutics Market in Saudi Arabia
o Projected Revenue of PE Therapeutics Market in South Africa

CHAPTER - 5: PE Therapeutics Market Prospects & Opportunities
- PE Therapeutics Market Opportunities & Trends
- PE Therapeutics Market Drivers
- PE Therapeutics Market Constraints

CHAPTER - 6: PE Therapeutics Industry Overview
- PE Therapeutics Market - Competitive Landscape
- PE Therapeutics Market - Key Vendor Profiles
- PE Therapeutics Market - Other Prominent Vendors
- PE Therapeutics Market - Key Strategic Recommendations

CHAPTER - 7: Appendix
- Research Methodology
- Abbreviations
- About Arizton

LIST OF EXHIBITS

Exhibit 1: Projected Revenues of PE Therapeutics in Global (2023-2029; $ Mn)
Exhibit 2: Projected Revenue of PE Therapeutics by SSRIs (2023-2029; $ Mn)
Exhibit 3: Projected Revenue of PE Therapeutics by PDE-5 Inhibitors ($ Mn)
Exhibit 4: Projected Revenues of PE Therapeutics by Anesthetic Agents (2023-2029; $ Mn)
Exhibit 5: Projected Revenues of PE Therapeutics by Others (2023-2029; $ Mn)
Exhibit 6: Projected Revenues of PE Therapeutics by Oral (2023-2029; $ Mn)
Exhibit 7: Projected Revenues of PE Therapeutics by Topical (2023-2029; $ Mn)
Exhibit 8: Projected Revenues of PE Therapeutics by Below 45 years (2023-2029; $ Mn)
Exhibit 9: Projected Revenues of PE Therapeutics by Above 45 years (2023-2029; $ Mn)
Exhibit 10: Projected Revenues of PE Therapeutics in North America (2023-2029; $ Mn)
Exhibit 11: Projected Revenues of PE Therapeutics in US (2023-2029; $ Mn)
Exhibit 12: Projected Revenues of PE Therapeutics in Canada (2023-2029; $ Mn)
Exhibit 13: Projected Revenues of PE Therapeutics in Europe (2023-2029; $ Mn)
Exhibit 14: Projected Revenues of PE Therapeutics in Germany (2023-2029; $ Mn)
Exhibit 15: Projected Revenues of PE Therapeutics in France (2023-2029; $ Mn)
Exhibit 16: Projected Revenues of PE Therapeutics in the UK (2023-2029; $ Mn)
Exhibit 17: Projected Revenues of PE Therapeutics in Italy (2023-2029; $ Mn)
Exhibit 18: Projected Revenues of PE Therapeutics in Spain (2023-2029; $ Mn)
Exhibit 19: Projected Revenues of PE Therapeutics in APAC (2023-2029; $ Mn)
Exhibit 20: Projected Revenues of PE Therapeutics in Japan (2023-2029; $ Mn)
Exhibit 21: Projected Revenues of PE Therapeutics in China (2023-2029; $ Mn)
Exhibit 22: Projected Revenues of PE Therapeutics in India (2023-2029; $ Mn)
Exhibit 23: Projected Revenues of PE Therapeutics in Latin America (2023-2029; $ Mn)
Exhibit 24: Projected Revenues of PE Therapeutics in Brazil (2023-2029; $ Mn)
Exhibit 25: Projected Revenues of PE Therapeutics in Mexico (2023-2029; $ Mn)
Exhibit 26: Projected Revenues of PE Therapeutics in Argentina (2023-2029; $ Mn)
Exhibit 27: Projected Revenues of PE Therapeutics in MEA (2023-2029; $ Mn)
Exhibit 28: Projected Revenues of PE Therapeutics in Turkey (2023-2029; $ Mn)
Exhibit 29: Projected Revenues of PE Therapeutics in Saudi Arabia (2023-2029; $ Mn)
Exhibit 30: Projected Revenues of PE Therapeutics in South Africa (2023-2029; $ Mn)

LIST OF TABLES

Table 1: Key Market Trends in the PE Therapeutics Market
Table 2: Key Market Enablers in PE Therapeutics Market
Table 3: Key Market Constraints in PE Therapeutics Market
Table 4: Strategic Recommendations in PE Therapeutics Market

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE